Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine

Expert Rev Vaccines. 2002 Oct;1(3):293-301. doi: 10.1586/14760584.1.3.293.

Abstract

To control the worldwide spread of HIV, a safe and effective prophylactic vaccine is urgently needed. Studies with the simian immunodeficiency virus demonstrated that a live attenuated virus can be effective as a vaccine, but serious concerns about the safety of such a vaccine virus have arisen. We propose a conditional live virus, of which the replication can be switched on and off at will, as a novel approach for an HIV vaccine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • AIDS Vaccines / adverse effects
  • AIDS Vaccines / immunology*
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Base Sequence
  • Doxycycline / pharmacology
  • Genetic Therapy
  • HIV Infections / prevention & control*
  • HIV-1 / immunology*
  • HIV-1 / metabolism
  • Humans
  • Molecular Sequence Data
  • SAIDS Vaccines / immunology
  • Vaccination
  • Vaccines, Attenuated / adverse effects
  • Vaccines, Attenuated / immunology*

Substances

  • AIDS Vaccines
  • Anti-Bacterial Agents
  • SAIDS Vaccines
  • Vaccines, Attenuated
  • Doxycycline